Strategikon Pharma names new chief commercial officer
6 November 2018 -

Strategikon Pharma, developer of a novel clinical trial planning, budgeting, outsourcing and vendor management tool, Clinical MaestroTM, has named Farah Ahmad as its new chief commercial officer, it was reported yesterday.

In this role, Farah will be responsible for strategy and implementation for market access and business development. Farah will report directly to founder and CEO, Anca Copaescu.

The company stated that Farah is a strategic and entrepreneurial business development leader with strong experience building successful sales teams, motivating top performers and driving growth in the clinical development segment. She joins Strategikon from Syneos Health, where she held the position of senior vice president, global business development leader for its Early Phase business unit.